Skip to content
Homepage
Author:
Zealand Pharma
Posted Date:
August 13, 2026
Zealand Pharma Announces Financial Results for the First Half of 2026
Zealand Pharma
August 13, 2026
Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide
Zealand Pharma
August 12, 2026
Zealand Pharma – Transactions related to share buy-back program (week 32, 2026)
Zealand Pharma
August 10, 2026
Zealand Pharma conference call on August 13 at 2pm CEST (8am ET) to present second quarter 2026 financial results
Zealand Pharma
August 6, 2026
Zealand Pharma – Transactions related to share buy-back program (week 31, 2026)
Zealand Pharma
August 3, 2026
